Company / Operating Cash Flow
Schrödinger, Inc. Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$13.9M
FY2025
5-year range
-$157.4M / $16.8M
FY2021-FY2025
Trend
+108.8%
vs FY2024
Sector context
#136 of 164
Health Care
What the data says
Schrödinger, Inc.'s operating cash flow of $14M is lower than 83% of companies in the Health Care sector (FY2025). Operating Cash Flow returned to growth in FY2025 after 2 years of decline, reaching $14M.
Based on SEC 10-K filings.
$14M in FY2025 with a 3-year CAGR of -6.0%.
Improved from -$137M to $14M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 164This company $13.9M Sector average $1.0B
▼
-98.7% below sector average
Key checks
Key Insights
- 3-year CAGR of -6.0%, indicating a declining trend.
- In FY2025, operating cash flow increased 108.8% year-over-year.
- Ranks #136 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.9M | +108.8% |
| FY2024 | -$157.4M | -15.1% |
| FY2023 | -$136.7M | -916.0% |
| FY2022 | $16.8M | +164.3% |
| FY2021 | -$26.1M | +0.0% |
| FY2020 | -$26.1M | +0.0% |
| FY2019 | -$26.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026